SIM
AMPH icon

Spark Investment Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Spark Investment Management’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-83,900
Closed -$1.19M – 764
2015
Q4 		$1.19M Sell
83,900
-35,300
-30% -$466K 0.15% 200
2015
Q3 		$1.39M Hold
119,200
– – 0.18% 182
2015
Q2 		$2.09M Hold
119,200
– – 0.29% 105
2015
Q1 		$1.78M Buy
119,200
+81,866
+219% +$1.09M 0.25% 123
2014
Q4 		$432K Buy
37,334
+16,134
+76% +$176K 0.07% 346
2014
Q3 		$246K Buy
+21,200
New +$221K 0.04% 478

Other funds holding AMPH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Spark Investment Management's AMPH Position: Q1 2016 in Review

Spark Investment Management sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2016, closing a stake of 83,900 shares — an estimated $1.19M sold.

Spark Investment Management first reported a position in AMPH in Q3 2014 and held it in 6 quarters. The position peaked at $2.09M in Q2 2015. 95 funds tracked by Wall St. Rank hold AMPH as of Q1 2016.

  • Spark Investment Management reported no remaining Amphastar Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • Spark Investment Management sold 83,900 Amphastar Pharmaceuticals shares in Q1 2016, an estimated $1.19M.
  • Spark Investment Management first reported a position in Amphastar Pharmaceuticals in Q3 2014 and held it in 6 quarters.
  • Spark Investment Management's Amphastar Pharmaceuticals position peaked at $2.09M in Q2 2015.
  • 95 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2016.

Based on Spark Investment Management's 13F filing for Q1 2016, filed 12 May 2016.